Unidoc Health Corp.
UDOCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $38 | $68 | $64 | $15 |
| Gross Profit | -$38 | -$68 | -$64 | -$15 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $18 | $12 | $353 |
| G&A Expenses | $0 | $791 | $894 | $2,186 |
| SG&A Expenses | $5,757 | $2,115 | $1,105 | $2,635 |
| Sales & Mktg Exp. | $0 | $211 | $211 | $449 |
| Other Operating Expenses | $0 | $0 | $238 | $15 |
| Operating Expenses | $5,757 | $2,132 | $1,355 | $3,003 |
| Operating Income | -$5,794 | -$2,201 | -$1,320 | -$3,003 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$269 | -$59 | -$37 | -$2 |
| Pre-Tax Income | -$6,063 | -$2,260 | -$1,357 | -$3,005 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6,063 | -$2,260 | -$1,357 | -$3,005 |
| % Margin | – | – | – | – |
| EPS | -0.11 | -0.12 | -0.062 | -0.27 |
| % Growth | 8.3% | -93.2% | 77% | – |
| EPS Diluted | -0.11 | -0.12 | -0.062 | -0.27 |
| Weighted Avg Shares Out | 55,822 | 50,341 | 21,867 | 10,933 |
| Weighted Avg Shares Out Dil | 55,822 | 50,341 | 21,867 | 10,933 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $99 | $9 | $9 | $2 |
| Depreciation & Amortization | $38 | $64 | $64 | $15 |
| EBITDA | -$5,927 | -$2,183 | -$1,284 | -$2,988 |
| % Margin | – | – | – | – |